Format

Send to

Choose Destination
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1969-76. doi: 10.1016/j.pnpbp.2011.09.009. Epub 2011 Sep 22.

Neuropsychological performance in OCD: a study in medication-naïve patients.

Author information

1
National Institute of Mental Health & Neuro Sciences (NIMHANS), Bangalore, India.

Abstract

BACKGROUND:

Obsessive-compulsive disorder (OCD) is associated with impairments in multiple neuropsychological domains but the findings are rather inconsistent across studies. One potential reason for poor replication is the confounding influence of medications. There is limited research on neuropsychological performance in medication-naïve, never treated OCD patients.

METHODS:

In this study, we assessed 31 medication-naïve, never-treated, DSM-IV OCD patients free of comorbid major depression and 31 healthy controls individually matched for age, gender and years of education, with tests of attention, executive function, memory reasoning and visuo-spatial function.

RESULTS:

Medication-naïve OCD patients did not significantly differ from healthy controls on most neuropsychological tests. Patients performed somewhat poorly only on the highest goal hierarchy of the Tower of London (TOL) test (p=0.001, effect size=0.68).

CONCLUSIONS:

It is intriguing to find that symptomatic, drug-naïve OCD patients did not significantly differ from healthy controls on most neuropsychological tests. Our finding of medium effect size on TOL highest goal hierarchy test suggests that brain regions outside the affective orbitofrontal loop may also be perhaps involved in OCD. This finding however needs replication because of modest effect size. Future studies should focus on studying medication-naïve, co-morbidity-free patients and relatives using symptom dimensions for consistent and robust findings.

PMID:
21967733
DOI:
10.1016/j.pnpbp.2011.09.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center